Patents by Inventor Frank W. Schmidtmann

Frank W. Schmidtmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as AR agonists
    Patent number: 8263762
    Abstract: Provided herein are alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: September 11, 2012
    Assignee: Dogwood Pharmaceuticals, Inc.
    Inventors: Anthony R. Beauglehole, Frank W. Schmidtmann, Jayson M. Rieger, Robert Thompson
  • Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as AR agonists
    Patent number: 8058259
    Abstract: The present invention provides substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: November 15, 2011
    Assignee: University of Virginia Patent Foundation
    Inventors: Robert Douglas Thompson, Anthony Beauglehole, Frank W. Schmidtmann, Jayson M. Rieger
  • ALKOXY-CARBONYL-AMINO-ALKYNYL-ADENOSINE COMPOUNDS AND DERIVATIVES THEREOF AS A2AR AGONISTS
    Publication number: 20110003766
    Abstract: Provided herein are alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
    Type: Application
    Filed: June 30, 2010
    Publication date: January 6, 2011
    Inventors: Anthony R. Beauglehole, Frank W. Schmidtmann, Jayson M. Rieger, Robert Thompson
  • INTRATHECAL TREATMENT OF NEUROPATHIC PAIN WITH A2AR AGONISTS
    Publication number: 20090181920
    Abstract: The present invention relates to a method of treating neuropathic pain via intrathecal administration of agonists of A2A adenosine receptors (ARs).
    Type: Application
    Filed: January 9, 2009
    Publication date: July 16, 2009
    Applicant: PGXHEALTH, LLC
    Inventors: Linda Watkins, Lisa C. Loram, Mark Hutchinson, Robert D. Thompson, Anthony Beauglehole, Frank W. Schmidtmann, Jayson M. Rieger
  • SUBSTITUTED 4--PIPERIDINE-1-CARBOXYLIC ACID ESTERS AS A2AR AGONISTS
    Publication number: 20090162282
    Abstract: The present invention provides substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters and pharmaceutical compositions containing the same that are selective agonists of A2A adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
    Type: Application
    Filed: December 18, 2008
    Publication date: June 25, 2009
    Inventors: Robert Douglas Thompson, Anthony Beauglehole, Frank W. Schmidtmann, Jayson M. Rieger